AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Total assets

annual total assets:

$3.50B+$28.88M(+0.83%)
December 31, 2024

Summary

  • As of today (August 17, 2025), AMRX annual total assets is $3.50 billion, with the most recent change of +$28.88 million (+0.83%) on December 31, 2024.
  • During the last 3 years, AMRX annual total assets has fallen by -$438.22 million (-11.12%).
  • AMRX annual total assets is now -19.56% below its all-time high of $4.35 billion, reached on December 31, 2018.

Performance

AMRX Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

quarterly total assets:

$3.42B+$57.54M(+1.71%)
June 30, 2025

Summary

  • As of today (August 17, 2025), AMRX quarterly total assets is $3.42 billion, with the most recent change of +$57.54 million (+1.71%) on June 30, 2025.
  • Over the past year, AMRX quarterly total assets has dropped by -$87.13 million (-2.48%).
  • AMRX quarterly total assets is now -25.30% below its all-time high of $4.58 billion, reached on September 30, 2018.

Performance

AMRX quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

AMRX Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.8%-2.5%
3 y3 years-11.1%-15.3%
5 y5 years-4.5%-15.6%

AMRX Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.1%+0.8%-15.3%+1.7%
5 y5-year-12.6%+0.8%-15.6%+1.7%
alltimeall time-19.6%>+9999.0%-25.3%>+9999.0%

AMRX Total assets History

DateAnnualQuarterly
Jun 2025
-
$3.42B(+1.7%)
Mar 2025
-
$3.37B(-3.9%)
Dec 2024
$3.50B(+0.8%)
$3.50B(+1.2%)
Sep 2024
-
$3.46B(-1.4%)
Jun 2024
-
$3.51B(+1.5%)
Mar 2024
-
$3.46B(-0.5%)
Dec 2023
$3.47B(-8.6%)
$3.47B(-5.8%)
Sep 2023
-
$3.69B(-0.4%)
Jun 2023
-
$3.70B(+2.0%)
Mar 2023
-
$3.63B(-4.5%)
Dec 2022
$3.80B(-3.6%)
$3.80B(-1.9%)
Sep 2022
-
$3.87B(-4.1%)
Jun 2022
-
$4.04B(+3.9%)
Mar 2022
-
$3.89B(-1.3%)
Dec 2021
$3.94B(-1.7%)
$3.94B(-0.9%)
Sep 2021
-
$3.97B(-1.2%)
Jun 2021
-
$4.02B(+1.6%)
Mar 2021
-
$3.96B(-1.1%)
Dec 2020
$4.01B(+9.3%)
$4.01B(-0.8%)
Sep 2020
-
$4.04B(-0.5%)
Jun 2020
-
$4.06B(-7.6%)
Mar 2020
-
$4.39B(+19.8%)
Dec 2019
$3.67B(-15.8%)
$3.67B(-1.0%)
Sep 2019
-
$3.70B(-13.1%)
Jun 2019
-
$4.26B(-2.8%)
Mar 2019
-
$4.38B(+0.7%)
Dec 2018
$4.35B(+224.4%)
$4.35B(-5.0%)
Sep 2018
-
$4.58B(+0.8%)
Jun 2018
-
$4.54B(>+9900.0%)
Mar 2018
-
$0.00(-100.0%)
Dec 2017
$1.34B(-26.4%)
$1.34B(-26.4%)
Dec 2016
$1.82B(-5.2%)
-
Dec 2016
-
$1.82B(-14.0%)
Sep 2016
-
$2.12B(+14.6%)
Jun 2016
-
$1.85B(-1.9%)
Mar 2016
-
$1.89B(-1.9%)
Dec 2015
$1.92B(+78.0%)
$1.92B(-3.7%)
Sep 2015
-
$2.00B(-1.8%)
Jun 2015
-
$2.03B(+14.0%)
Mar 2015
-
$1.78B(+65.0%)
Dec 2014
$1.08B(+8.1%)
$1.08B(-1.1%)
Sep 2014
-
$1.09B(+3.2%)
Jun 2014
-
$1.06B(+7.8%)
Mar 2014
-
$982.21M(-1.7%)
Dec 2013
$999.58M(+15.7%)
$999.58M(-1.5%)
Sep 2013
-
$1.01B(+0.5%)
Jun 2013
-
$1.01B(+0.1%)
Mar 2013
-
$1.01B(+16.8%)
DateAnnualQuarterly
Dec 2012
$863.97M(+8.8%)
$863.97M(-4.1%)
Sep 2012
-
$901.21M(-6.0%)
Jun 2012
-
$958.39M(+6.1%)
Mar 2012
-
$903.30M(+13.8%)
Dec 2011
$793.86M(+13.4%)
$793.86M(+5.5%)
Sep 2011
-
$752.36M(+1.2%)
Jun 2011
-
$743.57M(+3.6%)
Mar 2011
-
$717.67M(+2.5%)
Dec 2010
$700.33M(-0.4%)
$700.33M(-0.6%)
Sep 2010
-
$704.89M(-16.9%)
Jun 2010
-
$848.12M(+0.4%)
Mar 2010
-
$845.03M(+20.2%)
Dec 2009
$703.25M(+52.2%)
$703.25M(+32.7%)
Sep 2009
-
$529.89M(+2.7%)
Jun 2009
-
$516.00M(+0.8%)
Mar 2009
-
$512.13M(+10.9%)
Dec 2008
$461.98M(-1.4%)
$461.98M(-0.8%)
Sep 2008
-
$465.59M(-3.8%)
Jun 2008
-
$484.05M(+3.3%)
Dec 2007
$468.52M(+36.2%)
$468.52M(+36.2%)
Dec 2006
$343.89M(+32.1%)
$343.89M(+52.5%)
Dec 2005
$260.29M(+96.1%)
-
Sep 2004
-
$225.49M(-2.9%)
Jun 2004
-
$232.29M(+54.5%)
Mar 2004
-
$150.34M(+13.3%)
Dec 2003
$132.71M(+27.1%)
$132.71M(+3.6%)
Sep 2003
-
$128.06M(+0.8%)
Jun 2003
-
$127.07M(+19.1%)
Mar 2003
-
$106.69M(+2.2%)
Dec 2002
$104.40M(+7.0%)
$104.40M(+6.3%)
Sep 2002
-
$98.17M(-1.4%)
Jun 2002
-
$99.60M(+0.6%)
Mar 2002
-
$99.04M(+1.5%)
Dec 2001
$97.61M(+45.0%)
$97.61M(+1.8%)
Sep 2001
-
$95.90M(-0.6%)
Jun 2001
-
$96.52M(+59.0%)
Mar 2001
-
$60.69M(-9.8%)
Dec 2000
$67.31M(+9.1%)
$67.31M(+13.7%)
Sep 2000
-
$59.19M(-15.0%)
Jun 2000
-
$69.63M(-5.4%)
Mar 2000
-
$73.64M(+19.3%)
Dec 1999
$61.70M(+597.0%)
$61.70M(+370.2%)
Sep 1999
-
$13.12M(+5.0%)
Jun 1999
-
$12.49M(+9.1%)
Mar 1999
-
$11.46M(+29.4%)
Dec 1998
$8.85M
$8.85M(+3.9%)
Sep 1998
-
$8.52M(-2.9%)
Jun 1998
-
$8.77M(-14.9%)
Mar 1998
-
$10.31M

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual total assets?
  • What is the all time high annual total assets for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual total assets year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly total assets?
  • What is the all time high quarterly total assets for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly total assets year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual total assets?

The current annual total assets of AMRX is $3.50B

What is the all time high annual total assets for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual total assets is $4.35B

What is Amneal Pharmaceuticals, Inc. annual total assets year-on-year change?

Over the past year, AMRX annual total assets has changed by +$28.88M (+0.83%)

What is Amneal Pharmaceuticals, Inc. quarterly total assets?

The current quarterly total assets of AMRX is $3.42B

What is the all time high quarterly total assets for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly total assets is $4.58B

What is Amneal Pharmaceuticals, Inc. quarterly total assets year-on-year change?

Over the past year, AMRX quarterly total assets has changed by -$87.13M (-2.48%)
On this page